D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Tesla
TSLA
|
+$765M |
| 2 |
Baidu
BIDU
|
+$627M |
| 3 |
Coca-Cola
KO
|
+$444M |
| 4 |
NVIDIA
NVDA
|
+$380M |
| 5 |
Tencent Music
TME
|
+$344M |
Top Sells
| 1 |
Amazon
AMZN
|
+$957M |
| 2 |
Wells Fargo
WFC
|
+$743M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$604M |
| 4 |
GameStop
GME
|
+$532M |
| 5 |
DuPont de Nemours
DD
|
+$420M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Consumer Discretionary | 13.32% |
| 3 | Healthcare | 10.88% |
| 4 | Communication Services | 10.66% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHR
2226
Braemar Hotels & Resorts
BHR
$205M
| $697K | ﹤0.01% |
114,864
-201,930
| -64% | -$1.23M |
|
2227
Costamare
CMRE
$1.46B
| $693K | ﹤0.01% |
72,029
+14,887
| +26% | +$143K |
|
2228
Catalyst Pharmaceutical
CPRX
$2.46B
| $693K | ﹤0.01% |
150,392
-206,555
| -58% | -$952K |
|
|
DRNA
2229
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $693K | ﹤0.01% |
27,090
-88,755
| -77% | -$2.27M |
|
2230
Atmos Energy
ATO
$26.6B
| $692K | ﹤0.01% |
7,000
-55,035
| -89% | -$5.44M |
|
2231
ICF International
ICFI
$1.8B
| $692K | ﹤0.01% |
7,913
-5,365
| -40% | -$469K |
|
2232
Universal Health Services
UHS
$12B
| $692K | ﹤0.01% |
+5,191
| New | +$692K |
|
2233
Peabody Energy
BTU
$2.26B
| $689K | ﹤0.01% |
225,159
| – | – |
|
2234
Spok Holdings
SPOK
$362M
| $689K | ﹤0.01% |
65,738
-11,605
| -15% | -$122K |
|
|
MIME
2235
DELISTED
Mimecast Limited
MIME
| $689K | ﹤0.01% |
17,139
-41,290
| -71% | -$1.66M |
|
|
STR
2236
DELISTED
Sitio Royalties
STR
| $688K | ﹤0.01% |
38,288
-3,131
| -8% | -$56.3K |
|
2237
Andersons Inc
ANDE
$1.37B
| $686K | ﹤0.01% |
25,040
-38,527
| -61% | -$1.06M |
|
2238
Bridgewater Bancshares
BWB
$452M
| $686K | ﹤0.01% |
42,462
+6,579
| +18% | +$106K |
|
|
BDSI
2239
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $684K | ﹤0.01% |
174,834
-140,437
| -45% | -$549K |
|
2240
Itaú Unibanco
ITUB
$77.1B
| $680K | ﹤0.01% |
+182,933
| New | +$680K |
|
2241
Philip Morris
PM
$264B
| $676K | ﹤0.01% |
7,622
-83,948
| -92% | -$7.45M |
|
2242
Byline Bancorp
BY
$1.32B
| $674K | ﹤0.01% |
31,844
+11,066
| +53% | +$234K |
|
2243
Enpro
NPO
$4.73B
| $674K | ﹤0.01% |
7,896
-9,115
| -54% | -$778K |
|
2244
Rhythm Pharmaceuticals
RYTM
$6.65B
| $673K | ﹤0.01% |
+31,653
| New | +$673K |
|
2245
AZZ Inc
AZZ
$3.54B
| $672K | ﹤0.01% |
13,339
-5,380
| -29% | -$271K |
|
2246
Innospec
IOSP
$2.06B
| $672K | ﹤0.01% |
6,547
-11,556
| -64% | -$1.19M |
|
2247
Columbia Financial
CLBK
$1.61B
| $668K | ﹤0.01% |
+38,197
| New | +$668K |
|
2248
Westwood Holdings Group
WHG
$163M
| $667K | ﹤0.01% |
46,099
-9,054
| -16% | -$131K |
|
2249
Technology Select Sector SPDR Fund
XLK
$86.7B
| $664K | ﹤0.01% |
+5,000
| New | +$664K |
|
|
CADE
2250
DELISTED
Cadence Bancorporation
CADE
| $662K | ﹤0.01% |
+31,944
| New | +$662K |
|